{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T21:26:40Z","timestamp":1789075600064,"version":"build-2803163510"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,9,17]],"date-time":"2018-09-17T00:00:00Z","timestamp":1537142400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004748","name":"Mashhad University of Medical Sciences","doi-asserted-by":"publisher","award":["930603"],"award-info":[{"award-number":["930603"]}],"id":[{"id":"10.13039\/501100004748","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s11033-018-4387-1","type":"journal-article","created":{"date-parts":[[2018,9,17]],"date-time":"2018-09-17T02:54:34Z","timestamp":1537152874000},"page":"2257-2262","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Evaluation of serum level of substance P and tissue distribution of NK-1 receptor in endometrial cancer"],"prefix":"10.1007","volume":"45","author":[{"given":"Naghmeh","family":"Gharaee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"Pourali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir Hossein","family":"Jafarian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1323-5250","authenticated-orcid":false,"given":"Seyed Isaac","family":"Hashemy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,17]]},"reference":[{"issue":"2","key":"4387_CR1","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1124\/pr.54.2.285","volume":"54","author":"C Severini","year":"2002","unstructured":"Severini C, Improta G, Falconieri-Erspamer G, Salvadori S, Erspamer V (2002) The tachykinin peptide family. Pharmacol Rev 54(2):285\u2013322","journal-title":"Pharmacol Rev"},{"issue":"1","key":"4387_CR2","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1152\/physrev.00031.2013","volume":"94","author":"MS Steinhoff","year":"2014","unstructured":"Steinhoff MS, von Mentzer B, Geppetti P, Pothoulakis C, Bunnett NW (2014) Tachykinins and their receptors: contributions to physiological control and the mechanisms of disease. Physiol Rev 94(1):265\u2013301. \n                    https:\/\/doi.org\/10.1152\/physrev.00031.2013","journal-title":"Physiol Rev"},{"issue":"1","key":"4387_CR3","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1113\/jphysiol.1931.sp002763","volume":"72","author":"J Gaddum","year":"1931","unstructured":"Gaddum J (1931) An unidentified depressor substance in certain tissue extracts. J Physiol 72(1):74\u201387","journal-title":"J Physiol"},{"key":"4387_CR4","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/495704","author":"S Garcia-Recio","year":"2015","unstructured":"Garcia-Recio S, Gasc\u00f3n P (2015) Biological and pharmacological aspects of the NK1-Receptor. BioMed Res Int. \n                    https:\/\/doi.org\/10.1155\/2015\/495704","journal-title":"BioMed Res Int"},{"issue":"1","key":"4387_CR5","doi-asserted-by":"publisher","first-page":"75","DOI":"10.2174\/1568026043451636","volume":"4","author":"P Datar","year":"2004","unstructured":"Datar P, Srivastava S, Coutinho E, Govil G (2004) Substance P: structure, function, and therapeutics. Curr Top Med Chem 4(1):75\u2013103","journal-title":"Curr Top Med Chem"},{"issue":"5","key":"4387_CR6","first-page":"284","volume":"17","author":"C Bossaller","year":"1992","unstructured":"Bossaller C, Reither K, Hehlert-Friedrich C, Auch-Schwelk W, Graf K, Grafe M, Fleck E (1992) In vivo measurement of endothelium-dependent vasodilation with substance P in man. Herz 17(5):284\u2013290","journal-title":"Herz"},{"key":"4387_CR7","volume-title":"Substance P","author":"B Eklund","year":"1977","unstructured":"Eklund B, Jogestrand T, Pernow B (1977) Effect of substance P on resistance and capacitance vessels in the human forearm. In: von Euler US, Pernow B (eds) Substance P. Raven Press, New York"},{"issue":"2","key":"4387_CR8","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s00018-007-7148-1","volume":"65","author":"Y Shimizu","year":"2008","unstructured":"Shimizu Y, Matsuyama H, Shiina T, Takewaki T, Furness J (2008) Tachykinins and their functions in the gastrointestinal tract. Cell Mol Life Sci 65(2):295\u2013311","journal-title":"Cell Mol Life Sci"},{"issue":"2","key":"4387_CR9","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1254\/jphs.91.87","volume":"91","author":"R Saito","year":"2003","unstructured":"Saito R, Takano Y, Kamiya HO (2003) Roles of substance P and NK(1) receptor in the brainstem in the development of emesis. J Pharmacol Sci 91(2):87\u201394","journal-title":"J Pharmacol Sci"},{"issue":"3","key":"4387_CR10","first-page":"347","volume":"141","author":"HL Fields","year":"1984","unstructured":"Fields HL, Levine JD (1984) Pain\u2013mechanics and management. West J Med 141(3):347\u2013357","journal-title":"West J Med"},{"key":"4387_CR11","first-page":"51","volume":"3","author":"TE Klassert","year":"2010","unstructured":"Klassert TE, Patel SA, Rameshwar P (2010) Tachykinins and neurokinin receptors in bone marrow functions: neural-hematopoietic link. J Recept Ligand Channel Res 3:51\u201361","journal-title":"J Recept Ligand Channel Res"},{"issue":"3","key":"4387_CR12","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.jvs.2012.11.095","volume":"58","author":"LP Nabzdyk","year":"2013","unstructured":"Nabzdyk LP, Kuchibhotla S, Guthrie P, Chun M, Auster ME, Nabzdyk C, Deso S, Andersen N, Gnardellis C, LoGerfo FW (2013) Expression of neuropeptides and cytokines in a rabbit model of diabetic neuroischemic wound healing. J Vasc Surg 58(3):766\u2013775 (e712)","journal-title":"J Vasc Surg"},{"issue":"4","key":"4387_CR13","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1159\/000152942","volume":"29","author":"M Rosso","year":"2008","unstructured":"Rosso M, Robles-Fr\u00edas MJ, Cove\u00f1as R, Salinas-Mart\u00edn MV, Mu\u00f1oz M (2008) The NK-1 receptor is expressed in human primary gastric and colon adenocarcinomas and is involved in the antitumor action of L-733,060 and the mitogenic action of substance P on human gastrointestinal cancer cell lines. Tumor Biol 29(4):245\u2013254","journal-title":"Tumor Biol"},{"issue":"5","key":"4387_CR14","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1097\/01.LAB.0000067499.57309.F6","volume":"83","author":"H Friess","year":"2003","unstructured":"Friess H, Zhu Z, Liard V, Shi X, Shrikhande SV, Wang L, Lieb K, Korc M, Palma C, Zimmermann A (2003) Neurokinin-1 receptor expression and its potential effects on tumor growth in human pancreatic cancer. Lab Investig 83(5):731\u2013742","journal-title":"Lab Investig"},{"issue":"1","key":"4387_CR15","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1073\/pnas.97.1.388","volume":"97","author":"D Singh","year":"2000","unstructured":"Singh D, Joshi DD, Hameed M, Qian J, Gasc\u00f3n P, Maloof PB, Mosenthal A, Rameshwar P (2000) Increased expression of preprotachykinin-I and neurokinin receptors in human breast cancer cells: implications for bone marrow metastasis. Proc Natl Acad Sci USA 97(1):388\u2013393","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"4387_CR16","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.peptides.2012.09.024","volume":"38","author":"M Munoz","year":"2012","unstructured":"Munoz M, Gonzalez-Ortega A, Rosso M, Robles-Frias MJ, Carranza A, Salinas-Martin MV, Covenas R (2012) The substance P\/neurokinin-1 receptor system in lung cancer: focus on the antitumor action of neurokinin-1 receptor antagonists. Peptides 38(2):318\u2013325. \n                    https:\/\/doi.org\/10.1016\/j.peptides.2012.09.024","journal-title":"Peptides"},{"issue":"8","key":"4387_CR17","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1038\/labinvest.2010.92","volume":"90","author":"M Mu\u00f1oz","year":"2010","unstructured":"Mu\u00f1oz M, Rosso M, Robles-Frias MJ, Salinas-Mart\u00edn MV, Rosso R, Gonz\u00e1lez-Ortega A, Cove\u00f1as R (2010) The NK-1 receptor is expressed in human melanoma and is involved in the antitumor action of the NK-1 receptor antagonist aprepitant on melanoma cell lines. Lab Investig 90(8):1259\u20131269","journal-title":"Lab Investig"},{"issue":"2","key":"4387_CR18","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/0006-8993(78)90853-3","volume":"147","author":"J Harkins","year":"1978","unstructured":"Harkins J, Roper M, Ham RG, Stewart JM (1978) Biosynthesis of substance P in cultured mouse neuroblastoma and rat glioma cells. Brain Res 147(2):405\u2013409","journal-title":"Brain Res"},{"issue":"5","key":"4387_CR19","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1097\/igc.0000000000000683","volume":"26","author":"J Ma","year":"2016","unstructured":"Ma J, Yuan S, Cheng J, Kang S, Zhao W, Zhang J (2016) Substance P promotes the progression of endometrial adenocarcinoma. Int J Gynecol Cancer: Off J Int Gynecol Cancer Soc 26(5):845\u2013850. \n                    https:\/\/doi.org\/10.1097\/igc.0000000000000683","journal-title":"Int J Gynecol Cancer: Off J Int Gynecol Cancer Soc"},{"issue":"4","key":"4387_CR20","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1111\/j.1471-4159.2009.06032.x","volume":"109","author":"T Akazawa","year":"2009","unstructured":"Akazawa T, Kwatra SG, Goldsmith LE, Richardson MD, Cox EA, Sampson JH, Kwatra MM (2009) A constitutively active form of neurokinin 1 receptor and neurokinin 1 receptor-mediated apoptosis in glioblastomas. J Neurochem 109(4):1079\u20131086","journal-title":"J Neurochem"},{"issue":"10","key":"4387_CR21","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1097\/00001813-200511000-00007","volume":"16","author":"M Bigioni","year":"2005","unstructured":"Bigioni M, Benzo A, Irrissuto C, Maggi CA, Goso C (2005) Role of NK-1 and NK-2 tachykinin receptor antagonism on the growth of human breast carcinoma cell line MDA-MB-231. Anti-Cancer Drugs 16(10):1083\u20131089","journal-title":"Anti-Cancer Drugs"},{"issue":"9","key":"4387_CR22","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s00262-002-0300-8","volume":"51","author":"F Entschladen","year":"2002","unstructured":"Entschladen F, Lang K, Drell TL, Joseph J, Zaenker KS (2002) Neurotransmitters are regulators for the migration of tumor cells and leukocytes. Cancer Immunol Immunother 51(9):467\u2013482","journal-title":"Cancer Immunol Immunother"},{"issue":"7","key":"4387_CR23","doi-asserted-by":"publisher","first-page":"2738","DOI":"10.1158\/0008-5472.can-04-3197","volume":"65","author":"S Guha","year":"2005","unstructured":"Guha S, Eibl G, Kisfalvi K, Fan RS, Burdick M, Reber H, Hines OJ, Strieter R, Rozengurt E (2005) Broad-spectrum G protein-coupled receptor antagonist, [D-Arg1,D-Trp5,7,9,Leu11]SP: a dual inhibitor of growth and angiogenesis in pancreatic cancer. Cancer Res 65(7):2738\u20132745. \n                    https:\/\/doi.org\/10.1158\/0008-5472.can-04-3197","journal-title":"Cancer Res"},{"issue":"2","key":"4387_CR24","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s10637-010-9594-0","volume":"30","author":"M Munoz","year":"2012","unstructured":"Munoz M, Gonzalez-Ortega A, Covenas R (2012) The NK-1 receptor is expressed in human leukemia and is involved in the antitumor action of aprepitant and other NK-1 receptor antagonists on acute lymphoblastic leukemia cell lines. Investig New Drugs 30(2):529\u2013540. \n                    https:\/\/doi.org\/10.1007\/s10637-010-9594-0","journal-title":"Investig New Drugs"},{"issue":"4","key":"4387_CR25","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.npep.2005.03.004","volume":"39","author":"M Munoz","year":"2005","unstructured":"Munoz M, Rosso M, Perez A, Covenas R, Rosso R, Zamarriego C, Piruat JI (2005) The NK1 receptor is involved in the antitumoural action of L-733,060 and in the mitogenic action of substance P on neuroblastoma and glioma cell lines. Neuropeptides 39(4):427\u2013432. \n                    https:\/\/doi.org\/10.1016\/j.npep.2005.03.004","journal-title":"Neuropeptides"},{"issue":"5","key":"4387_CR26","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136(5):E359\u2013E386. \n                    https:\/\/doi.org\/10.1002\/ijc.29210","journal-title":"Int J Cancer"},{"issue":"6","key":"4387_CR27","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.7314\/APJCP.2014.15.6.2461","volume":"15","author":"M Arab","year":"2014","unstructured":"Arab M, Noghabaei G, Kazemi SN (2014) Comparison of crude and age-specific incidence rates of breast, ovary, endometrium and cervix cancers in Iran, 2005. Asian Pac J Cancer Prevent: APJCP 15(6):2461\u20132464","journal-title":"Asian Pac J Cancer Prevent: APJCP"},{"issue":"suppl 5","key":"4387_CR28","doi-asserted-by":"publisher","first-page":"v41","DOI":"10.1093\/annonc\/mdq245","volume":"21","author":"G Plataniotis","year":"2010","unstructured":"Plataniotis G, Castiglione M, Group EGW (2010) Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 21(suppl 5):v41\u2013v45","journal-title":"Ann Oncol"},{"issue":"2","key":"4387_CR29","doi-asserted-by":"publisher","first-page":"137","DOI":"10.4103\/0971-3026.155857","volume":"25","author":"SC Faria","year":"2015","unstructured":"Faria SC, Sagebiel T, Balachandran A, Devine C, Lal C, Bhosale PR (2015) Imaging in endometrial carcinoma. Indian J Radiol Imaging 25(2):137\u2013147. \n                    https:\/\/doi.org\/10.4103\/0971-3026.155857","journal-title":"Indian J Radiol Imaging"},{"key":"4387_CR30","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0809130106","author":"BY Reddy","year":"2009","unstructured":"Reddy BY, Greco SJ, Patel PS, Trzaska KA, Rameshwar P (2009) RE-1\u2013silencing transcription factor shows tumor-suppressor functions and negatively regulates the oncogenic TAC1 in breast cancer cells. Proc Natl Acad Sci. \n                    https:\/\/doi.org\/10.1073\/pnas.0809130106","journal-title":"Proc Natl Acad Sci"},{"key":"4387_CR31","doi-asserted-by":"publisher","DOI":"10.1100\/2012\/381434","author":"M Rosso","year":"2012","unstructured":"Rosso M, Munoz M, Berger M (2012) The role of neurokinin-1 receptor in the microenvironment of inflammation and cancer. Sci World J. \n                    https:\/\/doi.org\/10.1100\/2012\/381434","journal-title":"Sci World J"},{"issue":"5","key":"4387_CR32","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1073\/pnas.0530112100","volume":"100","author":"S Simeonidis","year":"2003","unstructured":"Simeonidis S, Castagliuolo I, Pan A, Liu J, Wang CC, Mykoniatis A, Pasha A, Valenick L, Sougioultzis S, Zhao D, Pothoulakis C (2003) Regulation of the NK-1 receptor gene expression in human macrophage cells via an NF-kappa B site on its promoter. Proc Natl Acad Sci USA 100(5):2957\u20132962. \n                    https:\/\/doi.org\/10.1073\/pnas.0530112100","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"4387_CR33","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1097\/01.LAB.0000067499.57309.F6","volume":"83","author":"H Friess","year":"2003","unstructured":"Friess H, Zhu Z, Liard V, Shi X, Shrikhande SV, Wang L, Lieb K, Korc M, Palma C, Zimmermann A, Reubi JC, Buchler MW (2003) Neurokinin-1 receptor expression and its potential effects on tumor growth in human pancreatic cancer. Lab Investig: A J Tech Methods Pathol 83(5):731\u2013742","journal-title":"Lab Investig: A J Tech Methods Pathol"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11033-018-4387-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-018-4387-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-018-4387-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T23:36:36Z","timestamp":1569972996000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11033-018-4387-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,17]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["4387"],"URL":"https:\/\/doi.org\/10.1007\/s11033-018-4387-1","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,17]]},"assertion":[{"value":"24 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}